Market definition of probiotic covers the microbiology of probiotic strains, Functional foods and Nutrition supplements, Probiotic and Prebiotic Foods, Digestive system and GI Experts, Gut Health, Microbiome and Genome health, Probiotics Value Chain, Therapy, treatment and medical management of disease areas such as inflammation, digestive disorders, the study of Gut-Brain-Axis and more recently the respiratory infection connection Gut-Lung-Axis, and all the market players who study, develop, promote and partner into the research and application of Probiotics Market Space.

The global probiotics market is majorly segmented by Types and Application, where the former includes Bifidobacterium, Lactobacillus, streptococcus, and the latter includes Functional Food and Beverages, Dietary Supplements, Animal Feed and Nutrition products, and Personal care. The product segment of Functional food and beverages is the largest with highest growth potential, as the intake of beverages, particularly functional beverages and dairy-based probiotics are very high. The product segment of dietary supplements is the fastest growing.

Market opportunities for Probiotics Space are due to

·         Increase in consumer awareness about the positive health impacts of probiotics and preventive healthcare

·         Life style modifications impacting eating habits and food choices. Resulted in increased prevalence unhealthy metabolic conditions like diabetes and obesity.

·         Demand rise has emphasized innovation in the manufacturing of probiotics and probiotic products

·         Healthy Gut for a Health Life trends the market, enhancing human and animal digestive health alongwith increasing demand for natural functional ingredients

·         Increasing prevalence of lifestyle and digestive metabolic disorders in the developing countries have moved the Global players in the Probiotics market space to explore and enter into untouched markets. Thus raising the New Market Development. 

·         After the successful scientific applications of Gut-Brain-Axis, the immunity booster product segment in Probiotics have taken the charge for Covid-19

·         Gut-Lung-Axis as the new trend in clinical and medical perspectives of probiotics being linked to the respiratory tract infection linked to Gut microbiota  

·         Although there is a lot of scope for innovation in the Therapeutic Application and Medical Development areas of Probiotics, but the Regulatory perspectives are putting up challenges.

·         In the absence of specific and stringent regulations for probiotics, there is no appropriate protection for the interests of producers whose objectives are to identify, study and market new probiotic products benefiting human health, or for the interests of the end users, who may be misled by product labeling or trademarks and deprived of information on the true nature of the product they are using. More strict regulations specifically addressing medically beneficial probiotics that are not classifiable as drugs would be welcome (https://www.sciencedirect.com/science/article/pii/S1542356518300843).

Key players in the Probiotic Market Space include Greentech, Biosearch, BioCC OÜ, Lallemand, Probi AB, CHR-Hansen, Novozymes, Roelmi HPC, UAS Laboratories LLC,  Probiotical, Kerry Group, Sabinsa Corporation, DowDupont Inc.,  Synbio Tech Inc., BioGaia AB, Danone, Ganeden,    Lifeway Foods, Nestle, Probi AB, Protexin, Yakult Honsha Co.